AMCP guide to pharmaceutical payment methods, 2009 update

Journal of Managed Care Pharmacy

Volumn 15, Issue 6 SUPPL. A, 2009, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG APPROVAL; DRUG COST; DRUG FORMULARY; DRUG MANUFACTURE; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE FACILITY; HOME CARE; HOSPITAL PATIENT; MEDICAID; MEDICAL CARE; MEDICARE; OUTPATIENT DEPARTMENT; PHARMACOGENOMICS; PHARMACY; PROSPECTIVE PAYMENT; PUBLIC HEALTH SERVICE; QUALITY CONTROL; REVIEW;

EID: 70349509185     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (171)

1. AMCP Task Force on Drug Payment Methodologies: AMCP guide to pharmaceutical payment methods. J Manag Care Pharm. 2007;13(8 Suppl C). Available at: http://www.amcp.org/page/PharmaceuticalPaymentMethodsIntro.
2. AMCP Drug Payment Resource Library. Available at: http://www.amcp.org/ page/DrugPaymentResourceLibrary.
3. Thomson Reuters. AWP policy. Revised February 17, 2004. Available at: www.micromedex.com/products/redbook/awp/AWP-Policy.pdf. Accessed July 15, 2009.
4. U.S. District Court, District of Massachusetts. New England Carpenters Health Benefits Fund, et al., plaintiffs, vs. First DataBank, Inc., and McKesson Corporation, defendants, Civil Action No. 05-11148-PBS; District Council 37 Health and Security Plan, on behalf of itself and all others similar situated, plaintiff, vs. Medi-Span, a division of Wolters Kluwer Health, Inc., defendant. Civil Action No. 07-10988-PBS. Memorandum and Order, March 17, 2009. Available at: http://www.nacds.org/user-assets/pdfs/gov-affairs/Issues/FirstDataBank/720- Memo-Order.pdf. Accessed July 15, 2009.
5. First Databank. AWP communications. Update regarding AWP litigation - final order and judgment entered. March 31, 2009. Available at: http://www.firstdatabank.com/Support/awp-communications.aspx. Accessed July 24, 2009.
6. Medi-Span. Customer letter. Available at: http://www.medispan.com/Common/ PDF/CustomerLetter-April12009-FINAL.pdf. Accessed July 15, 2009.
7. McConnell K, Haren MC. Payers tightening management of specialty therapies. Biotechnol Healthcare. April 2009:35-37. Available at: http://www.nxtbook.com/nxtbooks/medimedia/bh-200904/#/0. Accessed July 15, 2009.
8. Pharmacy benefit management (PBM) companies provide administrative services under the pharmacy benefit, such as contracting with a network of pharmacies including mail service, developing and managing formularies, establishing payment levels for provider pharmacies, adjudicating pharmacy claims, operating pharmacy and member call center/help desk, and providing data reporting.
9. Medicaid Program: Multiple source drug definition. 42CFR Part 447, Federal Register. March 14, 2008;73(51):13785-88. Available at: http://edocket.access.gpo.gov/2008/08-1022.htm. Accessed July 18, 2009.
10. Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Public Law 110-275). Available at: http://frwebgate.access.gpo.gov/cgi-bin/ getdoc.cgi?dbname=110-cong-public-laws&docid=f:publ275.110.pdf. Accessed July 15, 2009.
11. American Society of Clinical Oncology. Hospital outpatient prospective payment system payment policies for calendar year 2009: Overview of final rule provisions affecting reimbursement for oncology. Available at: http://prostateca.asco.org/ASCO/ArticleASCO/ Cancer%20Policy%20and%20Clinical%20Affairs/Policy/MMA%20Regulation%20& %20Resources/2009%20HOPPS%20Overview%20of%20Final%20Rule.pdf. Accessed July 15, 2009.
12. DHHS Centers for Medicare & Medicaid Services. Current CAP activity. Available at: http://www.cms.hhs.gov/CompetitiveAcquisforBios. Accessed July 15, 2009.
13. Kaiser Family Foundation. United States: Medicaid managed care enrollees as a percent of state Medicaid enrollees, as of June 30, 2007. State Health Facts.org. Available at: http://www.statehealthfacts.kff.org/profileind.jsp?ind= 217&cat=4&rgn=1. Accessed July 15, 2009.
14. Garfield R. Carving-out prescription drugs from Medicaid managed care: a review of the evidence. Pennsylvania Medicaid Policy Center. May 2009. Available at: http://www.pamedicaid.pitt.edu/documents/Carve%20Out-rp-09.pdf. Accessed July 15, 2009. http://www.communityplans.net/POLICYSUPPORT/Medicaid/ PrescriptionDrugs/tabid/97/Default.aspx
15. The AMCP Format for Formulary Submissions version 2.1. J Manag Care Pharm. 2005;11(5 Suppl B):i-xvi,1-29,1-6. Available at: http://www.amcp.org/ data/jmcp/formatsupp.pdf.
16. Stakeholders including payers and their consultants and representatives, vendors in the channels of distribution, health professionals, policymakers, patient associations, and professional associations.
17. Catlin A, Cowan C, Heffler S, Washington B, and the National Health Expenditure Accounts Team. National health spending in 2005: the slow-down continues. Health Aff. 2007;26(1):142-53. Available at: http://content. healthaffairs.org/cgi/content/full/26/1/142. Accessed July 15, 2009.
18. IMS Health reports U.S. prescription sales grew 1.3 percent in 2008 to $291 billion. March 19, 2009. Available at: http://www.imshealth.com/ portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid= 078ce5b87dal0210VgnVCM100000ed152ca2RCRD&vgnextchannel= b5e57900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default. Accessed July 24, 2009.
19. IMS Health lowers 2009 global pharmaceutical market forecast to 2.5-3.5 percent growth. April 22, 2009. Available at: http://www.imshealth.com/portal/ site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid= 1e61fa8adbec0210VgnVCM100000ed152ca2RCRD&vgnextchannel= b5e57900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default. Accessed July 24, 2009.
20. Milliman Research Report. 2008 Milliman Medical Index. May 2008. Available at: http://www.milliman.com/expertise/healthcare/products-tools/mmi/ pdfs/milliman-medical-index-2008.pdf. Accessed July 15, 2009.
21. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626-33. Available at: http://content.nejm.org/cgi/reprint/360/6/626.pdf. Accessed July 18, 2009.
22. For example, see oral statement of Pamela Jones Harbour, Commissioner, Federal Trade Commission, before the Subcommittee on Health, Committee on Energy and Commerce, of the U.S. House of Representatives, June 11, 2009. Available at: http://energycommerce.house.gov/Press-111/20090611/testimony-harbour.pdf. Accessed July 15, 2009.
23. Detailed outline of the Promoting Innovations and Access to Life-Saving Medicine Act. Available at: http://energycommerce.house.gov/Press-111/20090311/ hr1427-detailedsummary.pdf. Accessed July 18, 2009.
24. Expert Report of S Schondelmeyer, PharmD, PhD, in NACDS and NCPA vs. DHHS and CMS, November 13, 2007. Available at: www.ncpanet.org/pdf/amp-ncpanacds- schondelmeyerreport.pdf. Accessed July 15, 2009.
25. Shondelmeyer SW. Changes to AMP and best price: impact on 340B pricing. Presented at: The 4th Annual 340B Coalition Winter Conference; February 1, 2008. Available at: http://www.drugdiscountmonitor.com/2008-winter/Steve- Schondelmeyer-Fri-830-onsite.ppt. Accessed July 15, 2009.
26. See testimony of Janet Rehnquist, Inspector General, Department of Health and Human Services. Senate Committee on Finance Hearing. March 1, 2002. Available at: http://oig.hhs.gov/testimony/docs/2002/020314fin.pdf. Accessed July 15, 2009.
27. U.S. District Court, District of Massachusetts. New England Carpenters Health Benefits Fund, Pirelli Armstrong Retiree Medical Benefits Trust, Teamsters Health and Welfare Fund of Philadelphia and Vicinity, Philadelphia Federation Teachers Health and Welfare Fund, and District 37 Health and Security Fund, plaintiffs, vs. First Databank, Inc., and McKesson Corporation, defendants. Civil Action No: 05-11148-PBS; November 14, 2006. Available at: http://www.prescriptionaccess.org/docs/FDB-prelim-approval-order2.pdf. Accessed July 15, 2009.
28. Martinez B. How quiet moves by a publisher sway billions in drug spending. Wall St J. October 6, 2006:A1. Available at: http://www.dc37.net/news/ newsreleases/2006/drugpricing-WallStJ.pdf. Accessed July 15, 2009.
29. Bell D, Stephens R. RxVillage audioconference. NACDS and McDermott, Will, and Emery. Pharmacy Litigation Trends, 2009. January 16, 2009. Available in the AMCP Interactive Resource Library at: http://www.amcp.org/amcp.ark?p=264A8FA5.
30. DHHS Office of Inspector General. Medicaid drug price comparisons: average manufacturer price to published prices. Report no. OE1-05-05-00240. June 2005. Available at: http://oig.hhs.gov/oei/reports/oei-05-05-00240.pdf. Accessed July 25, 2009.
31. Koon M. Industrywide litigation by definition. For The Defense. October 2005. Available at: http://el.shb.com/nl-images/SHBWebsite/PracticeAreas/Pharma/ Pubs/IndustrywideLitigation-2005.pdf. Accessed July 25, 2009.
32. Congressional Budget Office. Testimony: statement of Douglas Holtz-Eakin, Director. Payment for prescription drugs under Medicaid. Before the U.S. Senate Special Committee on Aging; July 20, 2005. Available at: www.cbo.gov/ftpdoc. cfm?index=6564&type=0&sequence=0. Accessed July 28, 2009.
33. The Pharmacy Benefit Management Institute. Prescription drug benefit cost and plan design report, 2008-2009 edition. Takeda Pharmaceuticals North America, Inc. November 2008. Available at: http://www.pbmi.com/2008-report/pdfs/ Revised-Report-20112009.pdf. Accessed July 28, 2009.
34. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108- cong-bills&docid=f:h1enr.txt.pdf. Accessed July 15, 2009.
35. AWP Pricing Policy and List. Redbook. Thomson Reuters. Available at: http://www.micromedex.com/products/redbook/awp. Accessed July 15, 2009.
36. Elsevier Gold Standard ProspectoRx. Available at: http://www.prospectorx. com/keyElements.htm. Accessed July 15, 2009.
37. DHHS Office of Inspector General. Memorandum report: Comparison of first-quarter 2008 average sales prices and average manufacturer prices: impact on Medicare reimbursement for third quarter 2008. Report no. OEI-03-08-00530. December 23, 2008. Available at: www.oig.hhs.gov/oei/reports/oei-03-08-00530. pdf. Accessed July 27, 2009.
38. DHHS Office of Inspector General. Medicare payment for irinotecan. Report no. OEI-03-08-00310. August 2008. Available at: http://www.oig.hhs.gov/oei/ reports/oei-03-08-00310.pdf. Accessed July 27, 2009.
39. DHHS Office of Inspector General. Medicaid drug price comparison: average sales price to average wholesale price. Report no. OEI-03-05-00200. June 2005. Available at: http://oig.hhs.gov/oei/reports/oei-03-05-00200.pdf. Accessed July 27, 2009.
40. MedPAC. Report to the Congress: impact of changes in Medicare payments for Part B drugs. January 2007. Available at: www.medpac.gov/publications/ congressional-reports/Jan07-PartB-mandated-report.pdf. Accessed July 25, 2009.
41. DHHS Office of Inspector General. Calculation of volume-weighted average sales price for Medicare Part B prescription drugs. Report No. OEI-03-05-00310. February 2006. Available at: http://oig.hhs.gov/oei/reports/oei-03-05-00310.pdf. Accessed July 24, 2009.
42. Congressional Budget Office. Budget Options, Volume 1, Health Care. December 2008. Available at: http://www.cbo.gov/ftpdocs/99xx/doc9925/12-18- HealthOptions.pdf. Accessed July 27, 2009.
43. DHHS Centers for Medicare & Medicaid Services. Determination of AMP. (Section 447.504)339. Available at: http://edocket.access.gpo.gov/cfr-2007/ octqtr/pdf/42cfr447.504.pdf. Accessed July 27, 2009.
44. Arnold & Porter, LLP. Client Advisory. CMS issues final rule implementing Medicaid provisions of Deficit Reduction Act. July 2007. Available at: http://www.arnoldporter.com/resources/documents/A&PCA- CMSIssuesFinalRuleImplementingMedicaidProvisionsofDeficitReductionAct-07092007. pdf. Accessed July 27, 2009.
45. DHHS Centers for Medicare & Medicaid Services. Center for Medicaid and State Operations. Letter to State Medicaid directors. SMDL 08-008, November 3, 2008. Available at: http://www.cms.hhs.gov/SMDL/downloads/SMD110308.pdf. Accessed July 27, 2009.
46. DHHS. Office of Inspector General. Comparison of Medicaid federal upper limit amounts to average manufacturer price. Report no. OE1-03-05-00110. June 2005. Available at: www.oig.hhs.gov/oei/reports/oei-03-05-00110.pdf. Accessed July 24, 2009.
47. Centers for Medicare & Medicaid Services, HHS. Determination of best price. Section 447.505):341-342 Available at: http://edocket.access.gpo.gov/cfr- 2007/octqtr/pdf/42cfr447.505.pdf. Accessed July 24, 2009.
48. Congressional Budget Office. Prices for brand-name drugs under selected federal programs. June 2005. Available at: http://www.cbo.gov/ftpdocs/64xx/ doc6481/06-16-PrescriptDrug.pdf. Accessed July 24, 2009.
49. Academy of Managed Care Pharmacy. Best price requirements of the Medicaid drug rebate program. Available at: http://www.amcp.org/amcp.ark?p=C08A49C3. Accessed July 15, 2009.
50. Families USA. Medicaid savings ideas - prescription drugs. June 21, 2005. Available at: http://www.aucd.org/docs/policy/medicaid/medicaid-savings-ideas- 062105.doc. Accessed July 24, 2009.
51. Health Care Financing Administration. Study of pharmaceutical benefit management. HCFA contract no. 500-97-0399/0097. PriceWaterhouseCoopers. June 2001. Available at: http://www.cms.hhs.gov/reports/downloads/cms-2001-4.pdf. Accessed July 31, 2009.
52. Social Security Online. Compilation of Social Security Laws. Use of average sales price payment methodology. 42 U.S.C. § 1395w-3a, Section 303(c)6(B). Available at: http://www.ssa.gov/OP-Home/ssact/title18/1847A.htm. Accessed July 18, 2009.
53. Testimony of Susan A. Hayes for the Committee on Oversight and Government Reform, Subcommittee on Federal Workforce. June 24, 2009. Available at: http://federalworkforce.oversight.house.gov/documents/20090625153735.pdf. Accessed July 31, 2009.
54. DHHS. Health Resources and Services Administration. Frequently asked questions. Available at: http://answers.hrsa.gov/cgi-bin/hrsa.cfg/php/enduser/ std-alp.php?&p-cv=1.49&p-cats=49&cat-lvl2=0. Accessed July 15, 2009.
55. DHHS. Health Resources and Services Administration. Growth of Section 340B covered entity sites. 340B Database. April 1, 2009. Available at: ftp://ftp.hrsa.gov/bphc/pdf/opa/April-charts.pdf. Accessed July 25, 2009.
56. Rubinstein E, Curtiss FR. How much spread in AWP pricing is unlawful? J Manag Care Pharm. 2007;13(6):515-516 Available at: http://www.amcp.org/data/ jmcp/pages%20515-16.pdf.
57. DHHS Centers for Medicare & Medicaid Services. Program information on Medicare, Medicaid, SCHIP, and other programs of the Centers for Medicare and Medicaid Services. CMS, DHHS; June 2002 edition. Available at: http://www.cms.hhs.gov/TheChartSeries/downloads/sec2-p.pdf. Accessed July 25, 2009.
58. Urban Institute and Health Policy Alternatives. Cost containment in Medicare: A review of what works and what doesn't. AARP Public Policy Institute. December 2008. Available at: http://assets.aarp.org/rgcenter/health/2008-18- medicare.pdf. Accessed July 15, 2009.
59. Hartman M, et al. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998. Health Aff. 2009;28(1):246-61. Available at: http://content.healthaffairs.org/cgi/content/ abstract/28/1/246. Accessed July 15, 2009.
60. Bach P. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626-33. Available at: http://content.nejm.org/ cgi/reprint/360/6/626.pdf. Accessed July 15, 2009.
61. MedPAC. Outpatient hospital services payment system. October 2008. Available at: http://www.medpac.gov/documents/MedPAC-Payment-Basics-08-OPD.pdf. Accessed July 15, 2009.
62. DHHS Centers for Medicare & Medicaid Services. Final CY 2009 payment policies for drugs, biologicals and radiopharmaceuticals for hospital outpatient departments. Fact Sheet. October 30, 2008. Available at: http://www.cms.hhs. gov/apps/media/press/factsheet.asp?Counter=3336&intNumPerPage= 10&checkDate=&checkKey=&srchType=1&numDays=3500&srchOpt= 0&srchData=&keywordType=All&chkNewsType=6&intPage=&showAll= &pYear=&year=&desc=&cboOrder=date. Accessed July 25, 2009.
63. Medicare program: Payment policies under the physician fee schedule and other revisions to part b for CY 2009, Fed Regist. v73 #224:69753, November 19, 2008. Available at: http://www.gpo.gov/fdsys/pkg/FR-2008-11-19/pdf/E8-26213.pdf. Accessed July 26, 2009.
64. Medicare program: Payment policies under the physician fee schedule and other revisions to Part B for CY 2010. CMS-1413-P. July 13, 2009. Available at: http://edocket.access.gpo.gov/2009/pdf/E9-15835.pdf. Accessed July 27, 2009.
65. Statement of Richard Friedman, Executive Chairman, BioScrip. Testimony before the subcommittee on Health, House Committee on Ways and Means, U.S. House of Representatives; July 13, 2006. Available at: http://waysandmeans.house.gov/ hearings.asp?formmode=view&id=5114. Accessed July 27, 2009.
66. DHHS Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 17; December 31, 2008. Available at: http://www.cms.hhs.gov/manuals/downloads/clm104c17.pdf. Accessed July 15, 2009.
67. Kaiser Family Foundation. Medicare prescription drug benefit fact sheet. March 2009. Henry J. Kaiser Family Foundation. Available at: http://www.kff.org/medicare/upload/7044-09.pdf. Accessed July 15, 2009.
68. Kaiser Family Foundation. Medicare: A Primer. January 2009. Available at: http://www.kff.org/medicare/7615.cfm. Accessed July 18, 2009.
69. MedPAC. Part D payment system. October 2008. Available at: http://www.medpac.gov/documents/MedPAC-Payment-Basics-08-PartD.pdf. Accessed July 15, 2009.
70. National Health Policy Forum. The Medicare drug benefit (Part D). January 15, 2009. Available at: http://www.nhpf.org/library/the-basics/Basics- MedicarePartD-01-15-09.pdf. Accessed July 25, 2009.
71. Avalere Health. Follow the dollar: understanding drug prices and beneficiary costs under Medicare Part D. Prepared for National Pharmaceutical Council; April 2006. Available at: http://d.scribd.com/docs/ 2nayr8qp9n3mxe55qg5t.pdf. Accessed July 15, 2009.
72. O'Sullivan J. Medicare Part D prescription drug benefit: a primer. CRS Report for Congress, RL34280. Updated March 18, 2008. Available at: http://aging.senate.gov/crs/medicare12.pdf. Accessed July 25, 2009.
73. The Boards of Trustees, Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. 2009 annual report of the boards of trustees of the federal hospital insurance and federal supplementary medical insurance trust funds. May 2009. Available at: www.cms.hhs.gov/ ReportsTrustFunds/downloads/tr2009.pdf. Accessed July 15, 2009.
74. DHHS Office of Inspector General. Comparing pharmacy reimbursement: Medicare Part D to Medicaid. Report no. OEI-03-07-00350. February 2009. Available at: http://www.oig.hhs.gov/oei/reports/oei-03-07-00350.pdf. Accessed July 15, 2009.
75. DHHS Centers for Medicare and Medicaid Services. Medicare clarifies 'negotiated prices' under Part D. January 6, 2009. Available at: http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=3392& intNumPerPage=10&checkDate=&checkKey=2&srchType=2&numDays= 0&srchOpt=0&srchData=part+d&keywordType=All&chkNewsType= 1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll=1&pYear=&year=0&desc= &cboOrder=date. Accessed July 27, 2009.
76. U.S. House of Representatives Committee on Oversight and Government Reform. Medicare Part D: Drug pricing and manufacturer windfalls. July 2008. Available at: http://oversight.house.gov/documents/20080724101850.pdf. Accessed July 25, 2009.
77. DHHS Centers for Medicare & Medicaid Services. Pub. 100-18 Medicare Prescription Drug Benefit Manual, CMS Manual System, Transmittal 2, July 18, 2008. Available at: http://www.cms.hhs.gov/Transmittals/Downloads/R2PDB.pdf. Accessed July 25, 2009.
78. DHHS Centers for Medicare & Medicaid Services. Pub 100-18. Medicare prescription drug benefit manual. CMS Manual System. Transmittal 2. July 18, 2008. Available at: http://www.cms.hhs.gov/PrescriptionDrugCovContra/downloads/ R2PDBv2.pdf. Accessed July 24, 2009.
79. Kipp RA, Ko C. Medicare Part D administrator survey: potential cost impacts resulting from CMS guidance on special protections for six protected drug classifications and section 176 of the Medicare Improvements for Patients and Provides Act of 2008 (MIPPA) (P.L. 110-275). October 16, 2008. Available at: http://www.amcp.org/cfr/waSys/f.cfc?method=getLinkAsset&id=4979E963. Accessed July 26, 2009.
80. DHHS Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual, Chapter 13, Local Coverage Determinations. Available at: http://www.cms.hhs.gov/manuals/downloads/pim83c13.pdf. Accessed July 15, 2009.
81. Social Security Online. Exclusions from coverage and Medicare as secondary payer. 42 U.S.C. §1395y(a)(1)(A). Available at: http://www.ssa.gov/OP-Home/ssact/title18/1862.htm. Accessed July 25, 2009.
82. Drugs covered in state LCA policy. April 28, 2008. Available at: http://www.auanet.org/content/practice-resources/reimbursement/lcadrugs.pdf. Accessed July 27, 2009.
83. Hays vs. Leavitt, Civil Action No. 08-01032(HHK), United States District Court for the District of Columbia, October 16, 2008. Available at: https://ecf.dcd.uscourts.gov/cgi-bin/show-public-doc?2008cv1032-22. Accessed July 15, 2009.
84. Medical Payment Advisory Commission. Improving incentives in the Medicare program. Report to Congress. June 2009. Available at: http://www.medpac.gov/ documents/Jun09-EntireReport.pdf. Accessed July 25, 2009.
85. Medical Payment Advisory Commission. Durable medical equipment payment system. October 2008. Available at: http://www.medpac.gov/documents/MedPAC- Payment-Basics-08-DME.pdf. Accessed July 25, 2009.
86. Social Security Online. Social Security Act. Part E: miscellaneous provisions. Definitions of services, institutions, etc. April 9, 2007. §1861(s)(2)(Z); 1861(zz). Available at: http://www.ssa.gov/OP-Home/ssact/ title18/1861.htm. Accessed July 25, 2009.
87. National Governors Association & National Association of State Budget Officers. The fiscal survey of states. June 2008. Available at: http://www.nga.org/Files/pdf/FSS0806.PDF. Accessed July 25, 2009.
88. Kaiser Family Foundation. Medicaid: a primer. January 2009. Available at: http://www.kff.org/medicaid/upload/7334-03.pdf. Accessed July 25, 2009.
89. Centers for Medicare & Medicaid Services. Medicaid state waiver demonstration projects. Available at: http://www.cms.hhs.gov/ MedicaidStWaivProgDemoPGI. Accessed July 25, 2009.
90. Hoffman E. Brief summaries of Medicare and Medicaid as of November 1, 2008. 2008 Statistical Supplement. Health Care Financing Review. Available at: http://www.cms.hhs.gov/MedicareMedicaidStatSupp/LT/itemdetail.asp?filterType= none&filterByDID=-99&sortByDID=1&sortOrder=ascending&itemID= CMS1217947&intNumPerPage=10. Accessed July 15, 2009.
91. DHHS Centers for Medicare & Medicaid Services. Medicaid prescription drug reimbursement information by state - quarter ending March 2009. Available at: http://www.cms.hhs.gov/Reimbursement/20-StateMedicaidRxReimb.asp#TopOfPage. Accessed July 25, 2009.
92. National Pharmaceutical Council. Pharmaceutical benefits under state medical assistance programs, 2005-2006. Available at: http://d.scribd.com/docs/ f0pci6f7129v94a9apb.pdf. Accessed July 25, 2009.
93. Kaiser Family Foundation. Kaiser Commission on Medicaid and the Uninsured. Dual eligibles: Medicaid's role in filling Medicare's gaps - issue brief. March, 2004. Available at: http://www.kff.org/medicaid/upload/Dual- Eligibles-Medicaid-s-Role-in-Filling-Medicare-s-Gaps.pdf. Accessed July 25, 2009.
94. DHHS Centers for Medicare & Medicaid Services. Medicare/Medicaid dual eligibles. Available at: http://www.cms.hhs.gov/DualEligible/01-Overview. asp#TopOfPage. Accessed July 25, 2009.
95. Kaiser Family Foundation. Kaiser Commission on Medicaid and the Uninsured. Dual eligibles: Medicaid's role for low income Medicare beneficiaries. February 2009. Available at: http://www.kff.org/medicaid/upload/ 4091-06.pdf. Accessed July 25, 2009.
96. Kaiser Family Foundation. Kaiser Commission on Medicaid and the Uninsured. Tracking Medicare health and prescription drug plans. Monthly report for March 2009. April 2, 2009. Available at: http://www.kff.org/medicare/upload/ medicaretracking0309.pdf. Accessed July 25, 2009.
97. Dixon D, Wright P. National drug code reporting requirements. EDS Provider Relations Organization. January 2009. Available at: http://files.medi-cal.ca.gov/pubsdoco/ndc/pdf/10060-ndc-powerpoint.pdf. Accessed July 25, 2009.
98. DHHS Centers for Medicare & Medicaid Services. Medicaid drug rebate program. January 25, 2007. Available at: http://www.cms.hhs.gov/ MedicaidDrugRebateProgram/13-UnitRebateCalc.asp. Accessed July 25, 2009.
99. U.S. Government Accountability Office. Medicaid drug rebate program: inadequate oversight raises concerns about rebates paid to states. Report No. GAO-05-102. February 2005. Available at: http://www.gao.gov/new.items/d05102. pdf. Accessed July 25, 2009.
100. Hearne J. Prescription drug coverage under Medicaid. RL30726. Report for Congress. Congressional Research Service. February 6, 2008. Available at: http://aging.senate.gov/crs/medicaid16.pdf. Accessed July 25, 2009.
101. DHHS Centers for Medicare & Medicaid Services. Medicaid prescription reimbursement information by State - Quarter ending December 2008. Available at: http://www.cms.hhs.gov/Reimbursement/20-StateMedicaidRxReimb.asp. Accessed July 25, 2009.
102. DHHS Office of Inspector General. Variation in state Medicaid drug prices. Report No. OEI-05-02-00681. September, 2004. Available at: http://oig.hhs.gov/oei/reports/oei-05-02-00681.pdf. Accessed July 25, 2009.
103. Deficit Reduction Act of 2005. February 8, 2006. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109-cong-public- laws&docid=f:publ171.109.pdf. Accessed July 28, 2009.
104. DHHS Centers for Medicare & Medicaid Services. Medicaid program: prescription drugs; final rule. DHHS; July 17, 2007. 42 CFR Part 447;
105. CMS-2238-FC. Fed Regist. Vol.72, No.136. Available at: http://fdsys.gpo.gov/fdsys/pkg/FR-2007-07-17/pdf/07-3356.pdf. Accessed July 28, 2009.
106. U.S. Census Bureau. Income, poverty and health insurance coverage in the United States: 2007. August 2008. Available at: http://www.census.gov/prod/ 2008pubs/p60-235.pdf. Accessed July 28, 2009.
107. Kaiser Family Foundation and Health Research and Educational Trust. Employer health benefits: 2008 annual survey. August 2008. Available at: http://ehbs.kff.org/pdf/7790.pdf. Accessed July 28, 2009.
108. U.S. General Accounting Office. Private health insurance: federal and state requirements affecting coverage offered by small businesses. September 2003. Report No. GAO-03-1133. Available at: http://www.gao.gov/new.items/ d031133.pdf. Accessed July 28, 2009.
109. Employee Benefit Research Institute. ERISA and health plans. Special report SR-31. Issue brief #167. November 1995. Available at: http://www.ebri.org/publications/ib/index.cfm?fa=ibDisp&content-id=75. Accessed July 28, 2009.
110. Fronstin P. Capping the tax exclusion for employment-based health coverage: Implications for employers and workers. Employee Benefit Research Institute. January 2009. Available at: http://www.ebri.org/pdf/briefspdf/EBRI- IB-1-2009-TaxCap1.pdf. Accessed July 28, 2009.
111. Jordan H, Barth L, Jureidini S, Wrobel M. Identification and description of industry best practices to manage the costs of prescription drugs. Abt Associates, Inc.; November 11, 2005. Task Order 100-03-0002. Available at: http://www.abtassociates.com/reports/ibp-costs-perscription-drugs.pdf. Accessed July 28, 2009.
112. MedPAC report to the Congress: Medicare payment policy. March 2009. Available at: http://www.medpac.gov/documents/Mar09-EntireReport.pdf. Accessed July 28, 2009.
113. Pharmaceutical Coalition Meeting - Transparency in Pharmaceutical Purchasing Solutions (TIPPS). HR Policy Association, November 11, 2008. Available at: http://www.pharmacoalition.org/docs/PharmaCoalition-Nov11-MtgBook. pdf. Accessed July 28, 2009.
114. Fein A. Pharmacy profits and Wal-Mart. Drug Channels. January 15, 2009. Available at: http://www.drugchannels.net/2009/01/pharmacy-profits-and-wal-mart. html. Accessed July 28, 2009.
115. AARP Public Policy Institute. Closing a gap in Medicare drug coverage. May 2009. Available at: http://www.aarp.org/research/ppi/health-care/rxdrugs/ articles/fs-medicare-gap.html. Accessed July 28, 2009.
116. Congressional Budget Office. Would prescription drug importation reduce U.S. drug spending? April 29, 2004. Available at: http://www.cbo.gov/ftpdocs/ 54xx/doc5406/04-29-PrescriptionDrugs.pdf. Accessed July 28, 2009.
117. Kaiser Family Foundation. Prescription drug trends. September 2008. Available at: http://www.kff.org/rxdrugs/upload/3057-07.pdf. Accessed July 28, 2009.
118. DHHS Task Force on Drug Importation. Report on prescription drug importation. December 2004. Available at: http://archive.hhs.gov/import- taskforce/Report1220.pdf. Accessed July 28, 2009.
119. National Association of Counties. NACo prescription drug discount card program. May, 2009. Available at: http://www.naco.org/MOTemplate.cfm?Section= Prescription-Drug-Program&Template=/TaggedPage/TaggedPageDisplay. cfm&TPLID=72&ContentID=25445. Accessed July 28, 2009.
120. How to use the Kent County Rx discount card. Area Agency on Aging of Western Michigan. Available at: http://www.aaawm.org/Kent%20RX%20card.shtml. Accessed July 28, 2009.
121. RiteAid Rx savings card. Available at: http://www.riteaid.com/pharmacy/ rx-savings.jsf. Accessed July 28, 2009
122. EMD Serono Injectables Digest, 5th Edition. February 2009. Available at: https://olr.dwainc.com/2559Digest/powerpoints.aspx?SectionID=4. Accessed July 28, 2009.
123. Murphy-Barron CM. Provider reimbursement. Milliman Research Report. March 2002. Available on page 95 of a Milliman report dated November 9, 2005 at: http://healthcoveragehawaii.org/taskforce/pdfs/Milliman.Proposal.pdf. Accessed July 31, 2009.
124. ECG Management Consultants. Capitation and risk contracting survey. American Medical Group Association. Available at: https://commerce.amga.org/ store/getfile.cfm?product-id=1456&file=2008-Capitation-Survey.pdf. Accessed July 28, 2009.
125. Prometheus: provider payment for high quality care. A white paper. May 2006. Washington, DC: Prometheus Payment, Inc. Available at: http://www.allhealth.org/BriefingMaterials/PROMETHEUS- ProviderPaymentforHighQualityCare-AWhitePaper-ExecutiveSummary-511.pdf. Accessed July 28, 2009.
126. NORC at the University of Chicago and Georgetown University Health Policy Institute. Physician-administered drugs: distribution and payment issues in the private sector. MedPAC; August 2003. Available at: http://www.medpac.gov/ publications/contractor-reports/Aug03-DrugsDist(cont)Rpt.pdf. Accessed July 15, 2009.
127. Managed Care Injectables Index, Zitter Group, Fall 2008. Available at: http://zitter.com/injectablesindex.html. Accessed July 15, 2009, 2009.
128. National Home Infusion Association. National definition of per diem. January 2006. Available at: http://www.nhianet.org/resource/hiec/per-diem.cfm. Accessed July 15, 2009.
129. National Association of Urban-Based HMOs. Medicaid pharmacy rebate program and Medicaid HMOs. February 2001. Available at: http://www.mhpa.org/- upload/MEDICAlD%20PHARMACY%20REBATE%20PROGRAM%20AND%20MEDICAID%20MCOs.pdf. Accessed Jury 28, 2009.
130. Human Resource Policy Association. Pharmaceutical coalition's transparency in pharmaceutical purchasing solutions - TIPPS - initiative. July 24, 2006. Available at: http://www.hrpolicy.org/memoranda/2006/06-129-Pharma- 1pager.pdf. Accessed July 28, 2009.
131. PricewaterhouseCoopers LLP. Study of pharmaceutical benefit management. Health Care Financing Administration; June 2001. Contract No. 500-97-0399/0097. Available at: http://www.cms.hhs.gov/reports/downloads/cms-2001-4.pdf. Accessed July 15, 2009.
132. 2009 Segal health plan cost trend survey. The Segal Company. Available at: http://www.segalco.com/publications/surveysandstudies/2009trendsurvey.pdf. Accessed July 28, 2009.
133. Baker T. Benefit design and specialty pharmacy: implications for the managed care marketplace. Presentation at Pharmaceutical Care Management Association (PCMA) meeting, Chicago, Illinois, April 25, 2006. Available at: http://pcmanet.org/assets/2008-03-24-Asset-Tom%20Baker.pdf. Accessed July 18, 2009.
134. Testimony of F Segrave, Vice President, Wal-Mart Pharmacy Division. Subcommittee on Oversight and Investigation of the Committee on Energy and Commerce, U.S. House of Representatives; December 7, 2004. Available at: http://archives.energycommerce.house.gov/reparchives/108/Hearings/ 12072004hearing1411/Segrave%20testimony.pdf. Accessed July 15, 2009.
135. Rhea S. Inflation Frustration: Higher prices for raw materials have begun to hit the cost of health productivity and GPOs are feeling the pressure. Mod Healthcare. September 1, 2008:S1-S5. Available at: http://www.novationco.com/ pressroom/industry-info/modern-healthcare-survey-2008.pdf. Accessed July 28, 2009.
136. Pharmaceutical Research and Manufacturers Association. Pharmaceutical Industry Profile 2008. March 2008. Available at: http://www.phrma.org/files/ 2008%20Profile.pdf. Accessed July 18, 2009.
137. Hoadley J. The prescription drug safety net: Access to pharmaceuticals for the uninsured. National Health Policy Forum. May 8, 2007. Available at: http://www.nhpf.org/library/background-papers/BP-DrugSafetyNet-05-09-07.pdf. Accessed July 15, 2009.
138. DHHS Office of Inspector General. Medicaid pharmacy - actual acquisition cost of generic prescription drug products. Report No. A-06-01-00053. March 14, 2002. Available at: http://oig.hhs.gov/oas/reports/region6/60100053.pdf. Accessed July 28, 2009.
139. Biotechnology Industry Organization. Principles on AWP reform. Available at: http://bio.org/healthcare/archive/medicare/awp.asp?p=yes. Accessed July 28, 2009
140. Data on file. Alexandria, VA: Tag & Associates, Inc.
141. RAND Compare. Effects of bundled payment policy options. Available at: http://www.randcompare.org/analysis/mechanism/bundled-payment. Accessed July 28, 2009.
142. Network for Regional Healthcare Improvement and Robert Wood Johnson Foundation. Pay for innovation or pay for standardization? How to best support the patient-centered medical home. February 2009. Available at: http://www.nrhi.org/downloads/NRHI-HowtoSupporttheMedicalHome.pdf. Accessed July 28, 2009.
143. Congressional Budget Office. Increasing transparency in the pricing of health care services and pharmaceuticals. June 5, 2008. Available at: http://www.cbo.gov/ftpdocs/92xx/doc9284/06-05-PriceTransparency.pdf. Accessed July 28, 2009.
144. National Health Policy Forum. Pharmacy benefit managers: a model for Medicare? Issue brief. Washington, DC: George Washington University; July 9, 2001. No.765. Available at: http://www.nhpf.org/library/details.cfm/2324. Accessed April 29, 2009.
145. National Health Policy Forum. The ABCs of PBMs. Issue brief. Washington, DC: George Washington University; October 27, 1999. Available at: http://www.nhpf.org/library/issue-briefs/IB749-ABCsofPBMs-10-27-99.pdf. Accessed July 15, 2009.
146. Cook A, Kornfield T, Gold M. The role of PBMs in managing drug costs: implications for a Medicare drug benefit. Mathematica Policy Research for the Henry J. Kaiser Family Foundation; January 2000. Available at: http://www.kff.org/medicare/upload/The-Role-of-PBMs-in-Managing-Drug-Costs- Implications-for-a-Medicare-Drug-Benefit.pdf. Accessed July 28, 2009.
147. Greene J, Hibbard J, Murray JF, Teutsch SM, Berger ML. The impact of consumer-directed health plans on prescription drug use. Health Affairs. 2008;27(4):1111-19. Abstract available at: http://content.healthaffairs.org/cgi/ content/abstract/27/4/1111. Accessed July 28, 2009.
148. Sullivan M. Health plan initiatives, trends and research in consumer-driven care. Blue Cross Blue Shield Association. October 20, 2008. Available at: http://www.bcbs.com/news/bluetvradio/consumerdriven2008/bcbsa- final-slides.ppt. Accessed July 28, 2009.
149. Employee Benefit Research Institute. Findings from the 2008 EBRI consumer engagement in health care survey. Issue brief #323. November 2008. Available at: http://www.ebri.org/publications/ib/index.cfm?fa=ibDisp&content-id=4110. Accessed July 28, 2009.
150. Stebbins MR, Kaufman DJ, Lipton HL. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services. J Manag Care Pharm. 2005;11(4):333-341 Available at: http://www.amcp.org/data/ jmcp/contemporary-333-341.pdf.
151. Pear R. U.S. to compare medical treatments. NY Times. February 15, 2009. Available at: http://www.nytimes.com/2009/02/16/health/policy/16health.html?src= linkedin. Accessed July 28, 2009.
152. DHHS Agency for Healthcare Research and Quality. Fiscal year 2008 annual performance report. Available at: http://www.ahrq.gov/about/cj2009/ AHRQ%20FY2008%20Annual%20Performance%20Report.pdf. Accessed July 28, 2009.
153. Examples: Oregon Health and Science University Center for Evidence Based Policy Drug Effectiveness Review Project (DERP). Available at: http://www.ohsu.edu/ohsuedu/research/policycenter/DERP/participating- organizations.cfm;
154. Institute for Clinical Systems Improvement. Available at: http://www.icsi.org/about/icsi-members-sponsors;
155. Blue Cross Blue Shield Technology Evaluation Center. Available at: http://www.bcbs.com/news/press/facts/tec.html. Accessed July 15, 2009.
156. Garber AM. Comparative effectiveness and the limits of evidence. Center for Health Policy. Stanford University. Presented at California Research Bureau. December 18, 2008. Available at: http://www.library.ca.gov/crb/08/Garber1208. pdf. Accessed July 28, 2009.
157. Executive Office of the President. Office of Management and Budget. Letter to the Honorable Nancy Pelosi from Peter Orszag. July 17, 2009. Available at: http://www.whitehouse.gov/omb/assets/legislative-letters/Pelosi-071709.pdf. Accessed July 24, 2009.
158. Singer P. Why we must ration health care. NY Times. July 15, 2009. Available at: http://www.nytimes.com/2009/07/19/magazine/19healthcare-t.html? scp=1&sq=why%20we%20must%20ration%20health&st=cse. Accessed July 28, 2009.
159. Pollack A. Drug deals tie prices to how well patient do. NY Times. April 23, 2009. Available at: http://www.nytimes.com/2009/04/23/business/23cigna.html? -r=1&pagewanted=print. Accessed July 28, 2009.
160. de Brantes F, D'Andrea G, Rosenthal MB. Should health care come with a warranty? Health Affairs. 2009;28(4)w678-87 (published online June 16, 2009). Abstract available at: http://content.healthaffairs.org/cgi/content/abstract/ hlthaff.28.4.w678?ijkey=a7J7Z9oXbmt0Q&keytype=ref&siteid=healthaff. Accessed July 28, 2009.
161. California Association of Health Plans. Never events: issue brief. February 2008. Available at: http://www.calhealthplans.org/documents/ DH03-NeverEventsPoliciesProvidingPmt.pdf. Accessed July 28, 2009.
162. DHHS. Realizing the potential of pharmacogenomics: opportunities and challenges. Report of the Secretary's Advisory Committee on Genetics, Health and Society. May 2008. Available at: http://oba.od.nih.gov/oba/SACGHS/reports/ SACGHS-PGx-report.pdf. Accessed July 28, 2009.
163. Some plans take the lead in covering KRAS testing, with handful making it part of prior authorization. Specialty Pharmacy News. March 2009.
164. U.S. Federal Trade Commission. Authorized generics: an interim report. June 2009. Available at: http://www.ftc.gov/os/2009/06/ P062105authorizedgenericsreport.pdf. Accessed July 28, 2009.
165. U.S. Federal Trade Commission, Bureau of Competition. Connecticut Hospital Association (CHA) - staff advisory opinion. December 20, 2001. Available at: http://www.ftc.gov/opa/2001/12/chaadvisopinionletter.shtm. Accessed July 28, 2009.
166. U.S. Court of Appeals for the Seventh Circuit. In Re Brand Name Prescription Drugs Antitrust Litigation. No.99-1167. Argued June 9, 1999. Decided July 13, 1999. Dec. No. 186 F.3d 781. Available at: http://bulk. resource.org/courts.gov/c/F3/186/186.F3d.781.99-1167.html. Accessed July 28, 2009.
167. Medicare Payment Advisory Commission. About MedPAC. Available at: http://www.medpac.gov/about.cfm. Accessed July 28, 2009.
168. Centers for Medicare & Medicaid Services. Medicare program: manufacturer submission of manufacturer's average sales price (ASP) data for Medicare Part B drugs and biologicals. Final rule. (CMS-1380-F). Fed Regist. September 16, 2004. Available at: http://www.cms.hhs.gov/ McrPartBDrugAvgSalesPrice/03-regulations.asp. Accessed July 28, 2009.
169. U.S. Food and Drug Administration. Orange Book: approved drug products with therapeutic equivalence evaluations. Available at: http://www.accessdata. fda.gov/scripts/cder/ob/default.cfm. Accessed July 28, 2009.
170. U.S. Federal Trade Commission, Bureau of Competition. Henry County Memorial Hospital - staff advisory opinion. April 10, 1997. Available at: http://www.ftc.gov/bc/adops/henry.shtm. Accessed July 28, 2009.
171. DHHS Centers for Medicare & Medicaid Services. Medicaid program; prescription drugs 42 CFR Part 447 (CMS-2238-FC). RIN 0938-A020. Available at: http://www.cms.hhs.gov/MedicaidGenInfo/Downloads/CMS2238FC.pdf. Accessed July 28, 2009.